1. Home
  2. SNCR vs MIST Comparison

SNCR vs MIST Comparison

Compare SNCR & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNCR
  • MIST
  • Stock Information
  • Founded
  • SNCR 2000
  • MIST 2003
  • Country
  • SNCR United States
  • MIST Canada
  • Employees
  • SNCR N/A
  • MIST N/A
  • Industry
  • SNCR EDP Services
  • MIST Biotechnology: Pharmaceutical Preparations
  • Sector
  • SNCR Technology
  • MIST Health Care
  • Exchange
  • SNCR Nasdaq
  • MIST Nasdaq
  • Market Cap
  • SNCR 101.2M
  • MIST 98.1M
  • IPO Year
  • SNCR 2006
  • MIST N/A
  • Fundamental
  • Price
  • SNCR $11.64
  • MIST $0.88
  • Analyst Decision
  • SNCR Strong Buy
  • MIST Strong Buy
  • Analyst Count
  • SNCR 1
  • MIST 2
  • Target Price
  • SNCR $13.00
  • MIST $17.00
  • AVG Volume (30 Days)
  • SNCR 136.0K
  • MIST 4.5M
  • Earning Date
  • SNCR 03-11-2025
  • MIST 03-13-2025
  • Dividend Yield
  • SNCR N/A
  • MIST N/A
  • EPS Growth
  • SNCR N/A
  • MIST N/A
  • EPS
  • SNCR 0.43
  • MIST N/A
  • Revenue
  • SNCR $173,594,000.00
  • MIST N/A
  • Revenue This Year
  • SNCR $6.40
  • MIST N/A
  • Revenue Next Year
  • SNCR N/A
  • MIST $1,105.43
  • P/E Ratio
  • SNCR $27.07
  • MIST N/A
  • Revenue Growth
  • SNCR 5.72
  • MIST N/A
  • 52 Week Low
  • SNCR $6.02
  • MIST $0.75
  • 52 Week High
  • SNCR $15.46
  • MIST $2.75
  • Technical
  • Relative Strength Index (RSI)
  • SNCR 58.94
  • MIST 30.59
  • Support Level
  • SNCR $11.65
  • MIST $1.86
  • Resistance Level
  • SNCR $12.19
  • MIST $2.36
  • Average True Range (ATR)
  • SNCR 0.93
  • MIST 0.23
  • MACD
  • SNCR 0.11
  • MIST -0.06
  • Stochastic Oscillator
  • SNCR 78.85
  • MIST 7.43

About SNCR Synchronoss Technologies Inc.

Synchronoss Technologies Inc is a leading provider of white-label cloud, messaging, digital and network management solutions that enable its customers to keep subscribers, systems, networks and content in sync. The Synchronoss Personal CloudTM solution is designed to create an engaging and trusted customer experience through ongoing content management and engagement. The Synchronoss Personal CloudTM platform is a secure and highly scalable, white-label platform that allows its customers' subscribers to backup and protect, engage with, and manage their personal content. The company derives revenue from subscriptions and transaction-based fees. A majority of the firm's revenue is generated in the United States, and the rest is from countries across the world.

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

Share on Social Networks: